Fidelity Investments
BOLT icon

Fidelity Investments’s Bolt Biotherapeutics BOLT Stock Holding History

Fidelity Investments’s Portfolio BOLT Stock Details BOLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-121
Closed -$705 – 5388
2025
Q2 		$705 Sell
121
-284
-70% -$1.88K ﹤0.01% 5007
2025
Q1 		$3.24K Sell
405
-6,058
-94% -$58.2K ﹤0.01% 4803
2024
Q4 		$69.2K Buy
6,463
+694
+12% +$8.39K ﹤0.01% 3696
2024
Q3 		$74.8K Buy
5,769
+1,438
+33% +$19.8K ﹤0.01% 3595
2024
Q2 		$65K Buy
4,331
+386
+10% +$7.62K ﹤0.01% 3475
2024
Q1 		$110K Sell
3,945
-15
-0.4% -$347 ﹤0.01% 3239
2023
Q4 		$88.7K Hold
3,960
– – ﹤0.01% 3262
2023
Q3 		$82.4K Hold
3,960
– – ﹤0.01% 3165
2023
Q2 		$101K Buy
3,960
+38
+1% +$1.21K ﹤0.01% 3155
2023
Q1 		$109K Hold
3,922
– – ﹤0.01% 3187
2022
Q4 		$102K Sell
3,922
-41
-1% -$1.12K ﹤0.01% 3207
2022
Q3 		$117K Sell
3,963
-25
-0.6% -$1.03K ﹤0.01% 3211
2022
Q2 		$162K Buy
3,988
+6
+0.2% +$233 ﹤0.01% 3181
2022
Q1 		$218K Sell
3,982
-70,766
-95% -$4.76M ﹤0.01% 3231
2021
Q4 		$7.33M Sell
74,748
-65,971
-47% -$12.5M ﹤0.01% 2237
2021
Q3 		$35.6M Sell
140,719
-1,115
-0.8% -$315K ﹤0.01% 1567
2021
Q2 		$43.9M Sell
141,834
-2,018
-1% -$819K ﹤0.01% 1502
2021
Q1 		$94.7M Buy
+143,852
New +$93.6M 0.01% 1085

Other funds holding BOLT

VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $849M AUM 55.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments's BOLT Position: Q3 2025 in Review

Fidelity Investments sold out of Bolt Biotherapeutics (BOLT) in Q3 2025, closing a stake of 121 shares — an estimated $705 sold.

Fidelity Investments first reported a position in BOLT in Q1 2021 and held it in 18 quarters. The position peaked at $94.7M in Q1 2021. 24 funds tracked by Wall St. Rank hold BOLT as of Q3 2025.

  • Fidelity Investments reported no remaining Bolt Biotherapeutics position as of Q3 2025 after selling out during the quarter.
  • Fidelity Investments sold 121 Bolt Biotherapeutics shares in Q3 2025, an estimated $705.
  • Fidelity Investments first reported a position in Bolt Biotherapeutics in Q1 2021 and held it in 18 quarters.
  • Fidelity Investments's Bolt Biotherapeutics position peaked at $94.7M in Q1 2021.
  • 24 funds tracked by Wall St. Rank held Bolt Biotherapeutics as of Q3 2025.

Based on Fidelity Investments's 13F filing for Q3 2025, filed 13 Nov 2025.